MASLD in people with HIV exhibits higher fibrosis stage despite lower disease activity than in matched controls
Article in Alimentary Pharmacology & Therapeutics (September 2024)
The most recent citing publications are shown below. View all 6 publications that cite this research output on Dimensions.
Low MBOAT7 expression, a genetic risk for MASH, promotes a profibrotic pathway involving hepatocyte TAZ upregulation.
Article in Hepatology (May 2024)
Genetic polymorphisms of CYP2B6 is a risk of metabolic associated fatty liver disease in Chinese population
Article in Toxicology and Applied Pharmacology (November 2023)